Anxiolytics and hypnotics Flashcards

1
Q

what do anxiolytics and hypnotics treat?

A

anxiolytics treat anxiety

hypnotics treat sleep disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the fear response?

A
  • defensive behaviours
  • autonomic reflexes
  • alertness
  • negative emotion
  • corticosteroid secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is anxiety?

A

anticipatory fear response which is often independent of external events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are anxiety disorders?

A
  1. panic disorder - overwhelming fear marked by somatic symptoms such as tachycardia chest pains, trembling
  2. social anxiety - fear of interacting with people
  3. phobias - strong fear response to specific objects/situations
  4. PTSD - triggered by recall of a stressful situation
  5. OCD - compulsive, ritualistic behaviour driven by irrational anxiety
  6. generalised anxiety - no clear reason or focus, an ongoing state of excessive anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the treatment options for anxiety?

A
  1. anxiolytic/hypnotic agents - benziodiazepines (BZs) and barbiturates
    - BZs have unwanted side effects such as amnesia
    - BZs work instantly and are taken on a needed basis
  2. antidepressants - can take several weeks to produce a response and must be taken continuously
  3. propranolol (beta antagonist) to block somatic symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how are animals used to model anxiety?

A
  • animal behaviours associated with fear can help study and evaluate anxiety drugs
  • different models, experience and conditioning can give different results, reflecting the complexity of anxiety
  • shows how anxiolytic drugs suppress behaviours associated with fear, leading to overcoming fear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what animal models can be used to study anxiety?

A
  1. elevated cross test/light and dark box test
    - makes use of rodent’s fear of unfamiliar environment and desire to hide to avoid danger
    - the time the animal spends in the less exposed environment is measured
    - anxiolytic drugs reduce the fear response and hiding time of the animal
  2. conflict tests - trained response to reward may be interjected with electric shock associated with specific sound
    - in absense of anxiolytics, animal suppresses urge to get the reward when they hear the sound
    - when treated, they ignore the sound and get the reward
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what receptors are targets for anxiolytics and hypnotics?

A

GABAa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are GABAa receptors and their structure?

A
  • chloride-sensitive ionotropic receptors - activation causes hyperpolarisation and reduction in excitability
  • made up of 5 subunits - influences pharmacology
  • in different parts of brain, different subunit combinations are expressed
  • mediate fast inhibitory transmission
  • has multiple binding sites for different ligands: BZs, barbiturates and ethanol can increase GABAa function to inhibit CNS
  • 2 main binding sites - both must be occupied for GABAa to work
  • pentametric stoichiometry: 2alpha, 2beta, 1gamma/delta/epsilon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the orthosteric site of a receptor?

A

agonist binding site which is responsible for switching on the signalling by a receptor
- competitive antagonists may bind here to block the action of the agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the agonists and antagonists of the orthosteric site of GABAa?

A

agonists: GABA, muscimol

antagonist: bicuculline, picrotoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are allosteric sites of a receptor?

A

they do not switch on the signalling of a receptor themselves, but instead modify the function/signalling of the agonist-bound receptor

They only act if the orthosteric site is occupied by an agonist
If agonist is absent at orthosteric site, the allosteric site will not function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the agonists and antagonists of the allosteric site of GABAa?

A

agonist - benzodiazepoines e.g. diazepam (positive allosteric modulator)

antagonist - flumazenil (at BZ site)
- antagonist can be used to reverse BZ overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is an allosteric modulator?

A

it does not activate the receptor on its own, but it does modify the behaviour of the receptor when an agonist is bound to the orthosteric site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is a positive allosteric modulator (PAM)?

A

increases the signalling of an agonist-bound receptor
- BZs increase signalling of GABAa receptors
- only impact receptor if the orthosteric site is occupied by an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is a negative allosteric modulator?

A

decreases the signalling of an agonist-bound receptor
- beta-carboline decreases the signalling of GABAa receptors (opposite of BZ)

17
Q

what are the physiological effects of BZ agonists?

A
  1. sedation/anxiolytic: decreased responsiveness to constant level of stimulation
  2. hypnosis: latency of sleep onset is decreased
    - stage 2 sleep is increased and duration of rem is decreased
    - duration of slow wave sleep (night terrors) is decreased
  3. anterograde amnesia: prevent memory of events experienced while under influence
  4. anticonvulsant - inhibit development and spread of epileptiform activity
  5. reduction of muscle tone
18
Q

what are benzodiazepines?

A
  • used to treat anxiety and insomnia
  • positive allosteric modulatior of GABAa
  • activate midbrain dopamine neurons via GABAa to hijack mesolimbic reward system
  • induce muscle relaxation, control epileptic seizures and can produce amnesia
  • tolerance to the effects can be a sign of dependence - they can be abused after chronic clinical treatment for recreational purposes
19
Q

what mediates the sedative actions of BZs?

A

alpha1-containing GABAa receptors

20
Q

what mediates the anxiolytic actions of BZs?

A

alpha2-containing GABAa receptors

21
Q

what kind of ligand is BZs for GABAa receptors?

A

positive allosteric modulators - BZs increase activity of GABAa
- increase Cl- current across membrane, only in the presence of GABA bound to the receptor

22
Q

how do BZs and barbiturates modulate GABAa receptors?

A

BZs increase probability of GABAa opening

barbiturates increase the mean open time of GABAa

both result in more current flow and a bigger GABAa response

23
Q

what action does beta-carboline have on GABAa?

A

it is a negative allosteric modulator
- decrease channel opening so less inhibition of excitatory neurons
- it is anxiogenic so can increase anxiety
- it is a proconvulsant - can lead to seizures

24
Q

what action does flumazenil have on GABAa?

A

it is an antagonist at the BZ allosteric site
- it binds to an allosteric site so doesnt affect the receptor
- it can be used to reverse the effects of BZ overdose

25
Q

how do PAMs and NAMs affect GABAa receptors?

A

they exert opposite physiological effects:
- PAMs stabilise the receptor in a state with increased affinity for GABA, causing a left shift in conc-response curve
- NAMs stabilise receptor in a state with decreased affinity for GABA, so remains closed and harder to open (right shift)

26
Q

what are the therapeutic uses of BZs?

A
  • short acting compounds can be used as sleeping tablets
  • intravenous diazepam can treat epilepsy
  • some BZs are metabolised to produce active intermediates with a long half-life e.g. diazepam
  • BZ derivatives have anti-CCK activity which is a biological substrate for anxiety
  • sedative and muscle relaxant - causes impaired alertness
27
Q

what are the adverse affects of BZ agonists?

A
  1. tolerance - decreased responsiveness to a drug following continuous exposure
    - may be overcome by increasing dose
  2. misuse
  3. physical dependence characterised by withdrawal
    - increased anxiety, insomnia, CNS excitability, convulsions
    - more problematic with drugs with short half-lives e.g. triazolam may cause daytime anxiety when treating sleep disorders
    - may be alleviated by using a slower-acting drug
  4. sleepiness, impaired psychomotor function, amnesia
  5. can be fatal in overdose when taken with alcohol
28
Q

how do the conc-response curves of BZs and barbiturates differ?

A

barbiturates at high doses act as agonists and increase CNS depression to a fatal point

BZs have their own plateau affect, so at most put patient in deep sleep
- when mixed with CNS depressors such as alcohol however, BZs can be fatal

29
Q

what drugs are used to treat anxiety?

A
  1. benzodiazepines: use is limited, used for acute anxiety and co-administered with anti-depressants
  2. propranolol: beta-blocker to block symptoms of sympathetic drive
  3. antidepressants: SSRIs useful for generalised anxiety, PTSD and OCD
    - SSRIs and SNRIs and buspirone take several days to show effectiveness, so BZs are used in meantime
  4. buspirone: serotonin-1A partial agonist to treat generalised anxiety
    - acts on autoinhibitory GPCRs found on serotonergic neurons found in corticolimbic pathways to increase serotonin release
  5. antipsychotics: olanzapine to treat PTSD and generalised anxiety
  6. anti-epileptic drugs e.g. pregabalin to treat generalised anxiety
30
Q

what drugs can treat insomnia?

A

drug choice depends on underlying cause and whether short-term or chronic
- short-acting BZs e.g. lorazepam and zolpidem
- antihistamines - e.g. pyrromethene can cross the BBB to blocks histamine receptors to reduce alertness
- melatonin receptor agonists
- orexin receptor antagonists
- H1 receptor antagonists e.g. promethazine (sleep aid)

31
Q

what do single patch clamp recordings show about GABAa receptors?

A
  • some GABAa receptors spontaneously become active, even in absence of agonist
  • these moments are short lived
  • referred to as constitutive activity
  • inverse agonists can stabilise the receptor and reduce constitutive activity
32
Q

what are the new developments in treating PTSD?

A

EpiVario: mixing psychotherapy and small molecule drugs
- treats PTSD
- prevents consolidation of memory so people may use it before going into a stressful/traumatic situation e.g. army